In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

The Price War On Drugs: HCV Competition Finally Sparks Discounting

Executive Summary

The approval of Abbvie’s Viekira Pak combination HCV therapy has touched off a round of discounting in the high-profile specialty drug arena that is likely to bleed into other existing and future competitive markets.

You may also be interested in...



Pharma CEOs Tackle A Tough Question: “Why Don’t People Like You?”

Pfizer CEO Ian Read, Regeneron CEO Leonard Schleifer, Gilead CEO John Milligan and Lilly’s incoming CEO David Ricks discussed pharma’s reputation problem during the Forbes Healthcare Summit.

Nidda Sets Price For Stada Squeeze-Out

Nidda Healthcare, the investment vehicle controlled by Bain Capital and Cinven, has decided on a share price for the final squeeze-out of Stada’s remaining minority shareholders.

Alles Gut! German Gastrointestinal Launches From Bayer, Stada, Dr Kade

OTC marketing news from Germany: Bayer’s Talcid Liquid returns to pharmacy shelves, Stada extends its successful Probielle probiotics range and Dr Kade adds “gel” version of Riopan.

Topics

Related Companies

UsernamePublicRestriction

Register

SC141576

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel